GovChime
Notice ID: 692340ff312e4aeea48301fae6c7b35bAward NoticeAwarded

Phase 2 Clinical Trial to Investigate Novel Hosted Directed Therapeutics Candidates to Acute Respiratory Distress Syndrome (ARDS)

Awarded on December 15, 2023. Full description on SAM.gov.

Awarded tounder 75A50124C00001 (source: SAM.gov award notice)• $117.4M

Overview

Posted
December 29, 2023
Notice type
Award Notice
NAICS
541715: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Agency
Department of Health and Human Services

Notice details

Place of performance
To be determined based on proposals submitted., New York, NY, 10014
Last updated
Dec 6, 2025
Award date
Dec 15, 2023
Award amount (SAM.gov award notice)
$117.4M

Identifiers

Solicitation number
BAA-18-100-SOL-00003
Notice ID
692340ff312e4aeea48301fae6c7b35b
Award number (PIID)
75A50124C00001

Description

The contract awarded is a Cost Plus Incentive Fee contract in accordance with FAR 16.405-2

Full description on SAM.gov

Award Overview

Award Number

75A50124C00001

Award Amount (SAM.gov award notice)

$117.4M

Award Date

Dec 15, 2023

Awardee

Awardee UEI

ZANENSW6C665

Original Solicitation

Notice ID: 692340ff312e4aeea48301fae6c7b35b

Posted Date: Dec 29, 2023

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

5
  • 75N93022C00001
    PPD DEVELOPMENT, L.P.
    Department of Health and Human ServicesNAICS 541714
    $20.4MSigned Oct 26, 2026
  • 75N93024F00001
    PPD DEVELOPMENT, L.P.
    Department of Health and Human ServicesNAICS 541714
    $73.2MSigned Oct 14, 2026
  • 75N98026D00092
    PPD DEVELOPMENT LP
    Department of Health and Human ServicesNAICS 541714
    $10.0KSigned Sep 29, 2026
  • 75N93021F00001
    PPD DEVELOPMENT, L.P.
    Department of Health and Human ServicesNAICS 541714
    —Signed Sep 3, 2026
  • 75N93024F00002
    PPD DEVELOPMENT, L.P.
    Department of Health and Human ServicesNAICS 541714
    $26.1MSigned Aug 13, 2026

Contacts

Documents

No documents available.

Lifecycle

Solicitation:BAA-18-100-SOL-00003
  1. Pre-Solicitation
  2. Solicitation
  3. Awarded

This opportunity has been awarded.

  1. 3×
    Pre-SolicitationOct 16, 2017

    Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

    Notice 5e39c8f4430e3eda55a16a66df229c2f on SAM.gov

  2. AwardedMar 24, 2018

    Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

    Notice ea661fb1d6f9a68dcc8703725815e4d8 on SAM.gov

  3. 9×
    Pre-SolicitationJun 12, 2018

    Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

    Notice 417be22f7dad05a9f842352593b77da5 on SAM.gov

  4. 4×
    AwardedJul 9, 2019

    Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

    Notice 8daf6cc55c22c4740bb9e5b68ef39790 on SAM.gov

  5. SolicitationOct 15, 2019

    Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

    Notice 101e012dbb01f02fc7774c23a5d22bd0 on SAM.gov

  6. 3×
    AwardedCurrentSep 29, 2022

    Phase 2 Clinical Trial to Investigate Novel Hosted Directed Therapeutics Candidates to Acute Respiratory Distress Syndrome (ARDS)

    Notice 692340ff312e4aeea48301fae6c7b35b on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

BAA-18-100-SOL-00003

Archive Date

Jan 8, 2024

Office Address

Washington, DC, 20201